Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/14774
Title
The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
Author(s)
Date issued
2018-05-18
Citation
Cell Cycle . 2018;17(6):702-711.
Language
Inglés
Document type
journal article
Abstract
The transcriptional repressor Capicua (CIC) has emerged as an important rheostat of cell growth regulated by RAS/MAPK signaling. Cic was originally discovered in Drosophila, where it was shown to be inactivated by MAPK signaling downstream of the RTKs Torso and EGFR, which results in signal-dependent responses that are required for normal cell fate specification, proliferation and survival of developing and adult tissues. CIC is highly conserved in mammals, where it is also negatively regulated by MAPK signaling. Here, we review the roles of CIC during mammalian development, tissue homeostasis, tumor formation and therapy resistance. Available data indicate that CIC is involved in multiple biological processes, including lung development, liver homeostasis, autoimmunity and neurobehavioral processes. Moreover, CIC has been shown to be involved in tumor development as a tumor suppressor, both in human as well as in mouse models. Finally, several lines of evidence implicate CIC as a determinant of sensitivity to EGFR and MAPK pathway inhibitors, suggesting that CIC may play a broader role in human cancer than originally anticipated.
MESH
Signal Transduction | Animals | Drosophila | Drug Resistance, Neoplasm | Gene Expression Regulation, Developmental | Humans | Neoplasms | Protein Isoforms | Repressor Proteins | ras Proteins
Online version
DOI
Collections
Files in this item
![Acceso Abierto Acceso Abierto](/themes/Mirage2/images/openAccess.png)
- Name:
- TheCapicuatumorsuppressor_2018.pdf
- Size:
- 1.133Mb
- Format:
- Description:
- Artículo principal